Search Results - Grantier, C.

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    A PHASE II TRIAL OF BRENTUXIMAB VEDOTIN (BV) AND LENALIDOMIDE (LEN) IN RELAPSED AND REFRACTORY (R/R) CUTANEOUS (CTCL) AND PERIPHERAL (PTCL) T‐CELL LYMPHOMAS: PRELIMINARY RESULTS OF A PHASE II TRIAL

    A PHASE II TRIAL OF BRENTUXIMAB VEDOTIN (BV) AND LENALIDOMIDE (LEN) IN RELAPSED AND REFRACTORY (R/R) CUTANEOUS (CTCL) AND PERIPHERAL (PTCL) T‐CELL LYMPHOMAS: PRELIMINARY RESULTS OF... by William, B.M., Abbasi, A., Huang, Y., Larbi, R., Giali, R., Yang, L., Brammer, J., Grantier, C., Hoffman, C., Ayyappan, S., Baiocchi, R., Epperla, N., Christian, B., Alinari, L., Maddocks, K., Chung, C.

    Published in Hematological oncology
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Extended Follow up of a Phase 2 Study of Early Intervention with Lenalidomide in Patients with High-Risk Chronic Lymphocytic Leukemia

    Extended Follow up of a Phase 2 Study of Early Intervention with Lenalidomide in Patients with High-Risk Chronic Lymphocytic Leukemia by Rogers, Kerry A, Zhao, Qiuhong, Bhat, Seema A, Byrd, John C., Grantier, Cara, Grever, Michael R., Hoffman, Corinne, Kittai, Adam S, Lozanski, Gerard, Lucas, Margaret S., Rike, Lindsey, Thangavadivel, Shanmugapriya, Carson III, William E., Woyach, Jennifer A.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Outcomes of Patients with Chronic Lymphocytic Leukemia Discontinuing Bruton Tyrosine Kinase Inhibitors Due to Adverse Effects

    Outcomes of Patients with Chronic Lymphocytic Leukemia Discontinuing Bruton Tyrosine Kinase Inhibitors Due to Adverse Effects by Mansour, Anthony G, Huang, Ying, Alsouqi, Aseel, Kittai, Adam S, Byrd, John C., Grever, Michael R., Miller, Cecelia, Lozanski, Gerard, Moran, Mollie, Lucas, Margaret S., Suresh, Swetha, Grantier, Cara, Hoffman, Corinne, Reid, Mark, Rogers, Kerry A., Bhat, Seema A, Woyach, Jennifer A.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Pallidonigral TDP-43 pathology in Perry syndrome

    Pallidonigral TDP-43 pathology in Perry syndrome by Wider, Christian, Dickson, Dennis W, Stoessl, A. Jon, Tsuboi, Yoshio, Chapon, Françoise, Gutmann, Ludwig, Lechevalier, Bernard, Calne, Donald B, Personett, David A, Hulihan, Mary, Kachergus, Jennifer, Rademakers, Rosa, Baker, Matthew C, Grantier, Linda L, Sujith, O.K, Brown, Laura, Calne, Susan, Farrer, Matthew J, Wszolek, Zbigniew K

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Brentuximab Vedotin (BV) and Lenalidomide (Len) in Relapsed and Refractory (r/r) Cutaneous (CTCL) and Peripheral (PTCL) T-Cell Lymphomas; A Planned Interim Analysis of Phase II Trial

    Brentuximab Vedotin (BV) and Lenalidomide (Len) in Relapsed and Refractory (r/r) Cutaneous (CTCL) and Peripheral (PTCL) T-Cell Lymphomas; A Planned Interim Analysis of Phase II Tri... by William, Basem M., Huang, Ying, Johnson, Amy, Brammer, Jonathan E, Reneau, John C., Maakaron, Joseph, Larbi, Ruth, Grantier, Cara, Hoffman, Corinne, Ayyappan, Sabarish, Baiocchi, Robert A, Epperla, Narendranath, Christian, Beth A., Alinari, Lapo, Maddocks, Kami J., Chung, Catherine

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Electric-field-enhanced laser-induced plasma spectroscopy of jet-cooled silicon trimer

    Electric-field-enhanced laser-induced plasma spectroscopy of jet-cooled silicon trimer by Winstead, C.B., He, K.X., Grantier, D., Hammond, T., Gole, J.L.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: